Oncosil Medical Ltd is a leading medical technology company dedicated to revolutionizing cancer treatment. The company's core values include innovation, excellence, and patient-centricity. Oncosil Medical is driven by a corporate philosophy that emphasizes cutting-edge research, strategic partnerships, and delivering effective and safe medical solutions to patients worldwide. By leveraging its expertise in radiotherapy and brachytherapy, Oncosil Medical aims to improve the quality of life for cancer patients and provide them with new hope. With a commitment to advancing cancer therapies, Oncosil Medical Ltd stands as a reliable and compassionate ally in the fight against cancer.

Oncosil Medical Ltd is primarily present in Australia.

Oncosil Medical Ltd has achieved several significant milestones. Firstly, the company successfully completed its pivotal global clinical trial for the use of OncoSil™ as a treatment for pancreatic cancer. This trial demonstrated positive results and paved the way for regulatory approvals. Secondly, Oncosil Medical Ltd received CE Mark approval in Europe, allowing for the commercialization of OncoSil™ in the European Union. Furthermore, the company secured regulatory approval from the Australian Therapeutic Goods Administration. These achievements mark Oncosil Medical Ltd's progress in developing innovative solutions for cancer treatment, positioning the company as a leader in the field.

Oncosil Medical Ltd is an Australian-based medical technology company specializing in the development and commercialization of innovative products for the treatment of cancer. Established in 1995, Oncosil Medical Ltd has since focused on enhancing radiotherapy treatments through its unique targeted radiation therapy approach. The company's flagship product, the OncoSil™ device, is designed to deliver localized radiation directly to tumors, providing a more effective and targeted treatment option for patients. With a strong commitment to improving patient outcomes, Oncosil Medical Ltd continues to innovate and expand its product pipeline, aiming to revolutionize cancer treatment worldwide.

The main competitors of Oncosil Medical Ltd in the market include medical companies such as Varian Medical Systems, Isoray Inc., and Monarch Medical Technologies.

Oncosil Medical Ltd is primarily active in the healthcare industry.

The business model of Oncosil Medical Ltd focuses on developing and commercializing innovative medical devices for the treatment of various cancers. The company's flagship product, Oncosil™, is a minimally invasive implantable device that delivers a targeted dose of radiation directly to tumor sites. This unique approach aims to improve cancer treatment outcomes by enhancing the efficacy of radiation therapy while minimizing side effects. Oncosil Medical Ltd also collaborates with leading research institutions and medical centers to further advance the understanding and applications of its technology. By providing a targeted and precise treatment option, Oncosil Medical Ltd aims to improve the lives of cancer patients worldwide.

مُعامل القيمة السوقية إلى الأرباح لـ Oncosil Medical هو ؜-٠٫٢٢.

مُعامِل القيمة إلى المبيعات Oncosil Medical هو ١٫٧٢.

نقاط جودة AlleAktien لـ Oncosil Medical هي 6/10.

المتوقعة Oncosil Medical الإيرادات هي ٤٫٨٧ مليون. AUD.

صافي الربح المتوقعة Oncosil Medical هو ؜-٣٧٫٣١ مليون. AUD.

Oncosil Medical Ltd is an Australian-based medical company specializing in the development and marketing of innovative medical devices for tumor radiation therapy. The company aims to help cancer patients worldwide achieve a better quality of life.

يوزع Oncosil Medical أرباحًا قدرها 0 AUD من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Oncosil Medical في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـOncosil Medical هو AU000000OSL3.

رمز WKN لـ Oncosil Medical هو A1WZU4.

الرمز المُختصر لـ Oncosil Medical هو OSL.AX.

خلال آخر 12 شهراً، دفعت Oncosil Medical توزيعات أرباح بقيمة . وهذا يعادل عائد توزيعات أرباح يقارب . ومن المتوقع أن تدفع Oncosil Medical خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ0 AUD.

نسبة توزيعات الأرباح الحالية لـ Oncosil Medical هي .

Oncosil Medical يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر .

Oncosil Medical دفعت توزيعات الأرباح كل عام خلال الـ0 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة 0 AUD. وهذا يعادل عائد توزيعات أرباح قدره 0 %.

Oncosil Medical يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة 0 AUD من Oncosil Medical المُعلن عنها في ١٧‏/٧‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ١٧‏/٧‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ١٧‏/٧‏/٢٠٢٤.

في العام 2023، وزعت Oncosil Medical 0 AUD كأرباح أسهم.

يتم توزيع أرباح Oncosil Medical بالعملة AUD.